YS Biopharma Co Ltd (YS)
0.9451
0.00 (0.00%)
USD |
NASDAQ |
May 20, 13:05
YS Biopharma Gross Profit Margin (Quarterly): 81.92% for Sept. 30, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 81.92% |
| June 30, 2023 | 80.33% |
| Date | Value |
|---|---|
| September 30, 2022 | 78.06% |
| June 30, 2022 | 75.11% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
75.11%
Minimum
Jun 2022
81.92%
Maximum
Sep 2023
78.86%
Average
79.20%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Sinovac Biotech Ltd | -- |
| CASI Pharmaceuticals Inc | 59.05% |
| Zai Lab Ltd | 61.42% |
| Gracell Biotechnologies Inc (DELISTED) | -- |
| Adagene Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Assets | -11.69% |
| Return on Invested Capital | -32.36% |
| Profit Margin (Quarterly) | -108.4% |
| Operating Margin (Quarterly) | -103.3% |
| Return on Net Operating Assets | -12.52% |